Connection
Siva Uppalapati to Type C Phospholipases
This is a "connection" page, showing publications Siva Uppalapati has written about Type C Phospholipases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.372 |
|
|
|
-
Uppalapati SR, Kingston JJ, Murali HS, Batra HV. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein. Vaccine. 2014 May 23; 32(25):3075-81.
Score: 0.439
-
Uppalapati SR, Kingston JJ, Qureshi IA, Murali HS, Batra HV. In silico, in vitro and in vivo analysis of binding affinity between N and C-domains of Clostridium perfringens alpha toxin. PLoS One. 2013; 8(12):e82024.
Score: 0.430
-
Uppalapati SR, Kingston JJ, Murali HS, Batra HV. Generation and characterization of an inter-generic bivalent alpha domain fusion protein aCS from Clostridium perfringens and Staphylococcus aureus for concurrent diagnosis and therapeutic applications. J Appl Microbiol. 2012 Aug; 113(2):448-58.
Score: 0.386
-
Shreya D, Uppalapati SR, Kingston JJ, Sripathy MH, Batra HV. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model. Mol Immunol. 2015 May; 65(1):51-7.
Score: 0.116